4//SEC Filing
Dutia Suren G 4
Accession 0001213900-22-062484
CIK 0001506251other
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 4:09 PM ET
Size
18.2 KB
Accession
0001213900-22-062484
Insider Transaction Report
Form 4
Dutia Suren G
Director
Transactions
- Award
Options to Purchase Common Stock
2022-10-04+75,000→ 75,000 totalExercise: $1.25Exp: 2032-10-04→ Common Stock (75,000 underlying)
Holdings
- 75,000
Options to Purchase Common Stock
Exercise: $2.04Exp: 2031-10-11→ Common Stock (75,000 underlying) - 15,000
Options to Purchase Common Stock
Exercise: $2.00Exp: 2031-07-22→ Common Stock (15,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $1.69Exp: 2031-02-16→ Common Stock (25,000 underlying) - 35,000
Options to Purchase Common Stock
Exercise: $1.01Exp: 2030-10-06→ Common Stock (35,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 26,667
Options to Purchase Common Stock
Exercise: $8.10Exp: 2025-10-01→ Common Stock (26,667 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $1.39Exp: 2030-07-07→ Common Stock (25,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $0.67Exp: 2029-10-08→ Common Stock (25,000 underlying) - 15,000
Options to Purchase Common Stock
Exercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying)
Footnotes (10)
- [F1]The options were granted on October 4, 2022. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F10]The options granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.
- [F2]The options were granted on October 11, 2021. The options will vest 100% on the one-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of the vesting date.
- [F3]The options vested in full on July 22, 2022.
- [F4]The options vested in full on February 16, 2022.
- [F5]The options vested in full on October 6, 2021.
- [F6]The options vested in full on July 7, 2021.
- [F7]The options vested in full on October 8, 2020.
- [F8]The options vested in full on September 4, 2019.
- [F9]The options vested in full on September 13, 2018.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001514063
Filing Metadata
- Form type
- 4
- Filed
- Oct 5, 8:00 PM ET
- Accepted
- Oct 6, 4:09 PM ET
- Size
- 18.2 KB